Geode Capital Management
MDGL icon

Geode Capital Management’s Madrigal Pharmaceuticals MDGL Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$125M Sell
414,392
-6,483
-2% -$1.96M 0.01% 885
2025
Q1
$139M Buy
420,875
+10,297
+3% +$3.41M 0.01% 784
2024
Q4
$127M Buy
410,578
+4,923
+1% +$1.52M 0.01% 858
2024
Q3
$86.1M Buy
405,655
+5,801
+1% +$1.23M 0.01% 1084
2024
Q2
$112M Buy
399,854
+52,997
+15% +$14.9M 0.01% 860
2024
Q1
$92.6M Buy
346,857
+10,602
+3% +$2.83M 0.01% 962
2023
Q4
$77.8M Buy
336,255
+39,817
+13% +$9.21M 0.01% 1026
2023
Q3
$43.3M Buy
296,438
+25,119
+9% +$3.67M 0.01% 1323
2023
Q2
$62.7M Buy
271,319
+23,262
+9% +$5.37M 0.01% 1084
2023
Q1
$60.1M Buy
248,057
+11,472
+5% +$2.78M 0.01% 1059
2022
Q4
$68.7M Buy
236,585
+6,799
+3% +$1.97M 0.01% 939
2022
Q3
$14.9M Buy
229,786
+4,984
+2% +$324K ﹤0.01% 1960
2022
Q2
$16.1M Buy
224,802
+6,814
+3% +$488K ﹤0.01% 1915
2022
Q1
$21.4M Sell
217,988
-2,030
-0.9% -$199K ﹤0.01% 1858
2021
Q4
$18.6M Buy
220,018
+17,643
+9% +$1.5M ﹤0.01% 2005
2021
Q3
$16.1M Buy
202,375
+4,271
+2% +$341K ﹤0.01% 2106
2021
Q2
$19.3M Buy
198,104
+43,308
+28% +$4.22M ﹤0.01% 1988
2021
Q1
$18.1M Buy
154,796
+12,790
+9% +$1.5M ﹤0.01% 1949
2020
Q4
$15.8M Buy
142,006
+3,980
+3% +$442K ﹤0.01% 1869
2020
Q3
$16.4M Sell
138,026
-764
-0.6% -$90.7K ﹤0.01% 1667
2020
Q2
$15.7M Sell
138,790
-130
-0.1% -$14.7K ﹤0.01% 1662
2020
Q1
$9.27M Buy
138,920
+14,987
+12% +$1M ﹤0.01% 1770
2019
Q4
$11.3M Buy
123,933
+12,032
+11% +$1.1M ﹤0.01% 1930
2019
Q3
$9.65M Buy
111,901
+2,433
+2% +$210K ﹤0.01% 1960
2019
Q2
$11.5M Buy
109,468
+9,895
+10% +$1.04M ﹤0.01% 1851
2019
Q1
$12.5M Buy
99,573
+9,057
+10% +$1.13M ﹤0.01% 1746
2018
Q4
$10.2M Buy
90,516
+4,536
+5% +$511K ﹤0.01% 1776
2018
Q3
$18.4M Buy
85,980
+5,964
+7% +$1.28M 0.01% 1472
2018
Q2
$22.4M Buy
80,016
+28,514
+55% +$7.97M 0.01% 1272
2018
Q1
$6.01M Sell
51,502
-2,797
-5% -$327K ﹤0.01% 2122
2017
Q4
$4.98M Buy
54,299
+18,319
+51% +$1.68M ﹤0.01% 2218
2017
Q3
$1.62M Buy
35,980
+3,740
+12% +$168K ﹤0.01% 2861
2017
Q2
$524K Buy
32,240
+6,419
+25% +$104K ﹤0.01% 3340
2017
Q1
$397K Buy
25,821
+216
+0.8% +$3.32K ﹤0.01% 3393
2016
Q4
$381K Buy
25,605
+7,288
+40% +$108K ﹤0.01% 3370
2016
Q3
$232K Sell
18,317
-622,475
-97% -$7.88M ﹤0.01% 3544
2016
Q2
$166K Sell
640,792
-77,419
-11% -$20.1K ﹤0.01% 3653
2016
Q1
$172 Sell
718,211
-385
-0.1% ﹤0.01% 3679
2015
Q4
$252K Buy
718,596
+770
+0.1% +$270 ﹤0.01% 3593
2015
Q3
$1.25M Buy
717,826
+50,400
+8% +$87.7K ﹤0.01% 2744
2015
Q2
$1.49M Buy
667,426
+158,264
+31% +$353K ﹤0.01% 2675
2015
Q1
$987K Buy
509,162
+72,180
+17% +$140K ﹤0.01% 2890
2014
Q4
$1.16M Buy
436,982
+1,155
+0.3% +$3.06K ﹤0.01% 2755
2014
Q3
$1.31M Buy
435,827
+46,187
+12% +$139K ﹤0.01% 2624
2014
Q2
$1.59M Buy
389,640
+26,917
+7% +$110K ﹤0.01% 2522
2014
Q1
$1.56M Buy
362,723
+95,929
+36% +$413K ﹤0.01% 2492
2013
Q4
$1.4M Buy
266,794
+61,674
+30% +$323K ﹤0.01% 2515
2013
Q3
$1.29M Buy
205,120
+21,723
+12% +$137K ﹤0.01% 2453
2013
Q2
$915K Buy
+183,397
New +$915K ﹤0.01% 2512